Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Short-Term Debt repayments (2019 - 2025)

Historic Short-Term Debt repayments for China Pharma Holdings (CPHI) over the last 7 years, with Q3 2025 value amounting to -$617961.0.

  • China Pharma Holdings' Short-Term Debt repayments changed N/A to -$617961.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $474932.0, marking a year-over-year decrease of 7902.98%. This contributed to the annual value of $492761.0 for FY2024, which is 6692.99% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Short-Term Debt repayments is -$617961.0.
  • In the past 5 years, China Pharma Holdings' Short-Term Debt repayments ranged from a high of $1.5 million in Q3 2021 and a low of -$617961.0 during Q3 2025
  • Moreover, its 4-year median value for Short-Term Debt repayments was $467486.0 (2021), whereas its average is $514689.0.
  • Data for China Pharma Holdings' Short-Term Debt repayments shows a peak YoY increase of 136737.77% (in 2022) and a maximum YoY decrease of 10109.89% (in 2022) over the last 5 years.
  • Over the past 4 years, China Pharma Holdings' Short-Term Debt repayments (Quarter) stood at $85043.0 in 2021, then soared by 1367.38% to $1.2 million in 2022, then decreased by 17.15% to $1.0 million in 2023, then tumbled by 159.77% to -$617961.0 in 2025.
  • Its last three reported values are -$617961.0 in Q3 2025, $1.0 million for Q2 2025, and $76820.0 during Q1 2025.